Literature DB >> 7648217

The role of genetic factors in the development of end-stage renal disease.

B I Freedman1, D W Bowden.   

Abstract

Three etiologies of renal disease account for more than 80% of Medicare-supported (U.S. Federal Government sponsored) end-stage renal disease (ESRD) cases: diabetes mellitus, hypertension and chronic glomerulonephritis. Surprisingly, despite improvements in medical care, their incidence is increasing rapidly in many parts of the world. With the exception of autosomal dominant adult polycystic kidney disease, the DNA polymorphisms causing progressive renal failure in individuals with common diseases have not yet been identified. Although hypertension and diabetes mellitus are associated with ESRD, the majority of patients with these disorders never develop nephropathy. There is abundant evidence that both inherited factors and the environment affect the development of ESRD. Predisposition to nephropathy may be inherited independently from the environmental and hereditary components that produce the associated systemic disease. This review examines the evidence that ESRD results, in part, from inherited factors. It discusses the racially variable risk of renal disease, the familial clustering of ESRD and molecular genetic data in animals and humans with renal failure.

Entities:  

Mesh:

Year:  1995        PMID: 7648217     DOI: 10.1097/00041552-199505000-00005

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  3 in total

1.  -to: Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426-428.

Authors:  M J Zychma; J Gumprecht; P Rutkowski; W Grzeszczak
Journal:  Diabetologia       Date:  2003-11-12       Impact factor: 10.122

2.  Association of the human bradykinin B2 receptor gene with chronic renal failure.

Authors:  Lucyna Jozwiak; Andrzej Drop; Kinga Buraczynska; Piotr Ksiazek; Piotr Mierzicki; Monika Buraczynska
Journal:  Mol Diagn       Date:  2004

3.  Chemerin rs17173608 and vaspin rs2236242 gene variants on the risk of end stage renal disease (ESRD) and correlation with plasma malondialdehyde (MDA) level.

Authors:  Hamid Nomani; Hamid Khanmohamadian; Asad Vaisi-Raygani; Ebrahim Shakiba; Maryam Tanhapour; Zohreh Rahimi
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.